Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
Matthew Fankhauser, Yuen Tan, Geoff Macintyre, Izhak Haviv, Matthew KH Hong, Anne Nguyen, John S Pedersen, Anthony J Costello, Christopher M Hovens, Niall M Corcoran
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2014
Awarded by NHMRC grant
This work is supported by NHMRC grant 102408 (to N.M. Corcoran, J.S. Pedersen, A.J. Costello, and C.M. Hovens). N.M. Corcoran is supported by a David Bickart Clinician Research Fellowship from the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. G. Macintyre is supported by NICTA. NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program.